Oxford Nanopore Technologies PLC at Barclays Global Healthcare Conference Transcript

Mar 13, 2024 / 01:00PM GMT
Blanka Porkolab - Barclays - Analyst

Good morning. My name is Blanka Porkolab, and I sit within the European MedTech and services research team at Barclays. I'm very fortunate to have with me today Gordon Sanghera, CEO; and Nick Keher, CFO at Oxford Nanopore Technologies.

Thank you both for joining us today and a warm welcome to those in the room and those that have joined us online.

Questions and Answers:

Blanka Porkolab - Barclays - Analyst

Jumping straight into Q&A and starting with the group's outlook, how much of the top end of this year's sales outlook is dependent on these larger project wins that you spoke about at results last week? Could you get into the top end without any large wins?

Gordon Sanghera - Oxford Nanopore Technologies PLC - CEO

Nick, would you like to --

Nick Keher - Oxford Nanopore Technologies PLC - Chief Financial Officer, Executive Director

Yeah, of course. So important thing to recognize with the guidance that we've given is
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot